SHENZHEN, China, Nov. 18, 2016 /PRNewswire/ -- Asymchem Laboratories (Tianjin) Co., Ltd.,a leading contract manufacturer of Active Pharmaceutical Ingredients, today announced its Initial Public Offering (IPO) of 28,215,875 shares of A-share stock at a price of ?30.53 per share. The offering is anticipated to raise approximately ?861.43 million
Dr. Hao Hong, Chairman and CEO of Asymchem said: "I am confident that today marks the beginning of an important and exciting chapter for Asymchem. The driven team that I have the privilege of leading, together with the strengthening of our capital position today, will enable us to make Asymchem a clear leader in CMC contract manufacturing in the pharmaceutical industry worldwide."
"Becoming a listed company is an important milestone for Asymchem, and also a successful example of commercial capital operations support in Tianjin City," said Mr. Qingmin Yan, Deputy Mayor of Tianjin, at the bell ringing ceremony.
About Asymchem GroupAsymchem is a custom synthesis CMC contract manufacturer of cGMP intermediates and API's for the global pharmaceutical industry, providing compliant and sustainable manufacturing solutions worldwide over the lifecycle of a drug. Founded in 1995, USFDA and TGA inspected.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/asymchem-announces-its-initial-public-offering-300365917.html
SOURCE Asymchem Laboratories (Tianjin) Co., Ltd.
Subscribe to our Free Newsletters!
Spermatocele is a condition in which there is a blockage in the epididymal duct, resulting in semen ...
Be a blood donor and save lives for your donated blood is separated into blood products or just ...
Alzheimer's disease is an irreversible age-related brain disorder that destroys the memory ...View All